BG · NYQ · Consumer Defensive
Bunge Global SA
Also onShortfallConsensus DriftCrosscheck
Implied value per share
USD 81.86
Market price
USD 115.58
Implied upside
-29.2%
5-year forecast · Perpetuity growth terminal value · Mid-year discounting · Base case
Value Per Share
Same forecast, different terminal treatment. Percentages vs price.
Forecast Cashflows
Reporting currency (USD). Outflows negative.
| Line | FY26 | FY27 | FY28 | FY29 | FY30 | CAGR |
|---|---|---|---|---|---|---|
| Revenue | USD 71.4bn | USD 72.5bn | USD 73.6bn | USD 74.7bn | USD 75.8bn | +1.5% |
| EBIT | USD 2.4bn | USD 2.5bn | USD 2.5bn | USD 2.5bn | USD 2.6bn | +1.5% |
| NOPAT | USD 1.9bn | USD 1.9bn | USD 2.0bn | USD 2.0bn | USD 2.0bn | +1.5% |
| Add depreciation & amortisation | USD 579.2m | USD 588.0m | USD 596.9m | USD 605.9m | USD 615.0m | +1.5% |
| Less capital expenditure | USD -1.4bn | USD -1.4bn | USD -1.4bn | USD -1.4bn | USD -1.5bn | +1.5% |
| Less increase in working capital | USD -31.0m | USD -31.5m | USD -32.0m | USD -32.4m | USD -32.9m | +1.5% |
| Free cashflow to firm | USD 1.1bn | USD 1.1bn | USD 1.1bn | USD 1.1bn | USD 1.1bn | +1.5% |
| Discount factor | 0.9659 | 0.9011 | 0.8406 | 0.7842 | 0.7316 | - |
| Present value | USD 1.0bn | USD 988.1m | USD 935.7m | USD 886.2m | USD 839.2m | -5.3% |
| Present Value Of The Forecast | USD 4.7bn | |||||
Discount Rate
Source shown per component. All overridable above.
| Risk-free rate | 5.00% | US 10-year Treasury (^TNX) |
| Equity risk premium | 5.50% | Market assumption |
| Beta | 0.772 | Reported 0.660, pulled toward 1.0 (Blume) |
| Cost of equity | 9.25% | Risk-free + beta x equity risk premium |
| Cost of debt | 5.47% | Interest expense / average total debt |
| Market capitalisation | USD 22.2bn | 58.3% of capital |
| Total debt | USD 15.9bn | 41.7% of capital, book value as a proxy |
| Tax rate | 21.0% | Effective, capped at statutory |
| WACC | 7.19% | E/V x Re + D/V x Rd x (1 - t) |
Terminal Value
Perpetuity growth is intrinsic. The exit multiple defaults to the company's current EV/EBITDA, so it answers a different question - what the shares are worth if today's rating holds and EBITDA grows as forecast.
Perpetuity growth at 2.50%
84% of EV
- Forecast FCFF, final year
- USD 1.1bn
- Capex at depreciation, working capital in reinvestment
- USD 2.0bn
- Less reinvestment at g/ROIC (23.7% of NOPAT)
- USD -482.5m
- Capitalised
- USD 1.6bn
- ROIC (reported)
- 10.5%
- Terminal value, undiscounted
- USD 33.9bn
- Terminal value, discounted
- USD 24.8bn
- Enterprise value
- USD 29.5bn
- Less net debt
- USD 13.7bn
- Equity value
- USD 15.8bn
Exit at 17.9x EBITDA
90% of EV
- Terminal value, undiscounted
- USD 57.2bn
- Terminal value, discounted
- USD 41.9bn
- Enterprise value
- USD 46.5bn
- Less net debt
- USD 13.7bn
- Equity value
- USD 32.9bn
Spread between methods: 70%.
Sensitivity
Value per share (USD) by discount rate and long-run growth.
| Long-run growth | |||||
|---|---|---|---|---|---|
| Discount rate | 1.50% | 2.00% | 2.50% | 3.00% | 3.50% |
| 5.19% | 152.21 | 171.55 | 197.93 | 236.16 | 296.74 |
| 6.19% | 103.10 | 112.41 | 124.14 | 139.42 | 160.23 |
| 7.19% | 71.33 | 76.12 | 81.86 | 88.88 | 97.70 |
| 8.19% | 49.12 | 51.62 | 54.49 | 57.84 | 61.84 |
| 9.19% | 32.75 | 33.98 | 35.34 | 36.87 | 38.60 |
Outlined: this model. Green text: above today's price of 115.58. Shading: distance from this model's own value.
Priced In
What each input would have to be to justify the current price, one at a time.
| Input | Model | Implied | Gap |
|---|---|---|---|
| Revenue growth, every year | 1.5% | 6.2% | +4.7pp |
| EBIT margin | 3.4% | 4.1% | +0.7pp |
| Discount rate | 7.2% | 6.4% | -0.8pp |
Live formulas, not pasted numbers - edit a driver and the workbook reprices.
Yahoo Finance and RBA data. General information, not advice. Methodology.